Research and Markets: Portugal Pharmaceutical Pricing & Reimbursement Concise Guide

DUBLIN, Nov 12, 2010 (BUSINESS WIRE) -- Research and Markets ( has announced the addition of the "IMS Pricing & Reimbursement Concise Guide: Portugal" report to their offering.

The P&R Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered: HEALTHCARE SYSTEM Facts & Figures Market Indicators Provision & Funding PRICING Prescription Drugs Generic Drugs Hospital Drugs Innovative Products Non-Innovative Products Hospital Debts OTC Drugs REIMBURSEMENT Admission to Reimbursement Reimbursement Categories Reimbursement Prices Hospital Reimbursement Formularies Funding Changes in Reimbursement Status Reimbursement Reviews Reimbursed OTCs Reimbursement Categories Changes in Reimbursement Prices Manufacturers Revisions DGAEs Revisions Across-the-Board Cuts Generic Price Cuts Reference Price Revisions OTC Prices Pharmacoeconomics Pharmacoeconomic Requirements PRICE BUILD UP Wholesalers Retail Pharmacies Dispensing Doctors Sales Tax COST CONTAINMENT Industry Paybacks Promotional Costs Patient Co-payments Prescribing Controls Generics Substitution Rules INN Prescribing Conversion of Copies to Generics Rx-to-OTC Switches Parallel Trade FUTURE DEVELOPMENTS Outlook Names & Addresses For more information visit

Source: IMS Health SOURCE: Research and Markets CONTACT: Research and Markets Laura Wood, Senior Manager U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2010 -0- KEYWORD: Portugal


Other Health